Solbec Pharmaceuticals Ltd
Has secured funding from the Federal Government's Biotechnology Innovation Fund to develop research on its anti-cancer drug SBP002. The BiotechnologyInnovation Fund will fund half the $393,768 project. Trial results are expected in September 2004.
Above information supplied by: email:
© Business News 2017. You may share content using the tools provided but do not copy and redistribute.